enVVeno Medical (NVNO) Enterprise Value (2017 - 2020)
enVVeno Medical has reported Enterprise Value over the past 4 years, most recently at -$5.6 million for Q3 2020.
- Quarterly results put Enterprise Value at -$5.6 million for Q3 2020, down 91.24% from a year ago — trailing twelve months through Sep 2020 was -$5.6 million (down 91.24% YoY), and the annual figure for FY2019 was -$1.3 million, up 52.3%.
- Enterprise Value for Q3 2020 was -$5.6 million at enVVeno Medical, down from -$1.6 million in the prior quarter.
- Over the last five years, Enterprise Value for NVNO hit a ceiling of -$15916.0 in Q2 2017 and a floor of -$5.9 million in Q2 2018.
- Median Enterprise Value over the past 4 years was -$2.2 million (2018), compared with a mean of -$2.4 million.
- Biggest five-year swings in Enterprise Value: crashed 37236.16% in 2018 and later soared 73.84% in 2020.
- enVVeno Medical's Enterprise Value stood at -$77688.0 in 2017, then crashed by 3427.76% to -$2.7 million in 2018, then surged by 52.3% to -$1.3 million in 2019, then crashed by 330.61% to -$5.6 million in 2020.
- The last three reported values for Enterprise Value were -$5.6 million (Q3 2020), -$1.6 million (Q2 2020), and -$720131.0 (Q1 2020) per Business Quant data.